A citation-based method for searching scientific literature

Ya-Ting Qin, Yao-Jia Ma, Yu-Sheng Feng, Xi-Wen He, Wen-You Li, Yu-Kui Zhang. ACS Appl Mater Interfaces 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
100

Organelle-targeted photothermal agents for cancer therapy.
Eunbin Hwang, Hyo Sung Jung. Chem Commun (Camb) 2021
5
100

Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.
Jacek Zielonka, Joy Joseph, Adam Sikora, Micael Hardy, Olivier Ouari, Jeannette Vasquez-Vivar, Gang Cheng, Marcos Lopez, Balaraman Kalyanaraman. Chem Rev 2017
543
100

Multifunctional nanoparticles for multimodal imaging and theragnosis.
Dong-Eun Lee, Heebeom Koo, In-Cheol Sun, Ju Hee Ryu, Kwangmeyung Kim, Ick Chan Kwon. Chem Soc Rev 2012
758
100

Boosting Cancer Therapy with Organelle-Targeted Nanomaterials.
Peng Gao, Wei Pan, Na Li, Bo Tang. ACS Appl Mater Interfaces 2019
92
100

Precise design strategies of nanomedicine for improving cancer therapeutic efficacy using subcellular targeting.
Xianglei Fu, Yanbin Shi, Tongtong Qi, Shengnan Qiu, Yi Huang, Xiaogang Zhao, Qifeng Sun, Guimei Lin. Signal Transduct Target Ther 2020
27
100

Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione.
K Barnouin, I Leier, G Jedlitschky, A Pourtier-Manzanedo, J König, W D Lehmann, D Keppler. Br J Cancer 1998
80
100

Hetero-Trifunctional Malonate-Based Nanotheranostic System for Targeted Breast Cancer Therapy.
Tapan Kumar Dash, Diptendu Patra, Parvathy Venu, Biswajit Das, Rangeet Bhattacharyya, Raja Shunmugam. ACS Appl Bio Mater 2021
3
100

Mitochondrially targeted anti-cancer agents.
Lucia Biasutto, Lan-Feng Dong, Mario Zoratti, Jiri Neuzil. Mitochondrion 2010
94
100

Rerouting chlorambucil to mitochondria combats drug deactivation and resistance in cancer cells.
Sonali B Fonseca, Mark P Pereira, Rida Mourtada, Marcela Gronda, Kristin L Horton, Rose Hurren, Mark D Minden, Aaron D Schimmer, Shana O Kelley. Chem Biol 2011
72
100

Drug delivery to mitochondria: the key to mitochondrial medicine.
M P Murphy, R A Smith. Adv Drug Deliv Rev 2000
316
100

Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging.
Robert J McDonald, Jennifer S McDonald, David F Kallmes, Mark E Jentoft, David L Murray, Kent R Thielen, Eric E Williamson, Laurence J Eckel. Radiology 2015
854
100

Fe(deferasirox)2: An Iron(III)-Based Magnetic Resonance Imaging T1 Contrast Agent Endowed with Remarkable Molecular and Functional Characteristics.
Lorenzo Palagi, Enza Di Gregorio, Diana Costanzo, Rachele Stefania, Camilla Cavallotti, Martina Capozza, Silvio Aime, Eliana Gianolio. J Am Chem Soc 2021
7
100

Low-Molecular-Weight Iron Chelates May Be an Alternative to Gadolinium-based Contrast Agents for T1-weighted Contrast-enhanced MR Imaging.
Philipp Boehm-Sturm, Akvile Haeckel, Ralf Hauptmann, Susanne Mueller, Christiane K Kuhl, Eyk A Schellenberger. Radiology 2018
50
100


Mitochondria as a pharmacological target.
Adam Szewczyk, Lech Wojtczak. Pharmacol Rev 2002
369
100

Cancer nanomedicine: progress, challenges and opportunities.
Jinjun Shi, Philip W Kantoff, Richard Wooster, Omid C Farokhzad. Nat Rev Cancer 2017
100

Iron(III) Coordinated Polymeric Nanomaterial: A Next-Generation Theranostic Agent for High-Resolution T1-Weighted Magnetic Resonance Imaging and Anticancer Drug Delivery.
Diptendu Patra, Saikat Mukherjee, Ipsita Chakraborty, Tapan K Dash, Shantibhusan Senapati, Rangeet Bhattacharyya, Raja Shunmugam. ACS Biomater Sci Eng 2018
8
100


Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology.
Nicolas Bertrand, Jun Wu, Xiaoyang Xu, Nazila Kamaly, Omid C Farokhzad. Adv Drug Deliv Rev 2014
100

Mitochondrial dysfunction in cancer.
Josephine S Modica-Napolitano, Keshav K Singh. Mitochondrion 2004
228
100


Mitochondria in cancer cells: what is so special about them?
Vladimir Gogvadze, Sten Orrenius, Boris Zhivotovsky. Trends Cell Biol 2008
442
100


Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases.
Javier Perez-Rodriguez, Shenghan Lai, Benjamin D Ehst, Derek M Fine, David A Bluemke. Radiology 2009
150
100


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
100

MRI for breast cancer screening, diagnosis, and treatment.
Monica Morrow, Janet Waters, Elizabeth Morris. Lancet 2011
192
100

Gram-scale synthesis of coordination polymer nanodots with renal clearance properties for cancer theranostic applications.
Fuyao Liu, Xiuxia He, Hongda Chen, Junping Zhang, Huimao Zhang, Zhenxin Wang. Nat Commun 2015
124
100

Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase mu.
J K Horton, G Roy, J T Piper, B Van Houten, Y C Awasthi, S Mitra, M A Alaoui-Jamali, I Boldogh, S S Singhal. Biochem Pharmacol 1999
39
100

Combinatorial drug therapy for cancer in the post-genomic era.
Bissan Al-Lazikani, Udai Banerji, Paul Workman. Nat Biotechnol 2012
574
100

Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.
Jessica Wahsner, Eric M Gale, Aurora Rodríguez-Rodríguez, Peter Caravan. Chem Rev 2019
431
100


Mitochondrial form and function.
Jonathan R Friedman, Jodi Nunnari. Nature 2014
836
100

Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy.
Xiaowei Wang, Yuhan Qiu, Mengyan Wang, Conghui Zhang, Tianshu Zhang, Huimin Zhou, Wenxia Zhao, Wuli Zhao, Guimin Xia, Rongguang Shao. Int J Nanomedicine 2020
12
100


Defining the conditions for the development of the emerging class of FeIII-based MRI contrast agents.
Zsolt Baranyai, Fabio Carniato, Alessandro Nucera, Dávid Horváth, Lorenzo Tei, Carlos Platas-Iglesias, Mauro Botta. Chem Sci 2021
7
100

A selective mitochondrial-targeted chlorambucil with remarkable cytotoxicity in breast and pancreatic cancers.
Melissa Millard, John D Gallagher, Bogdan Z Olenyuk, Nouri Neamati. J Med Chem 2013
82
100

The anti-cancer drug chlorambucil as a substrate for the human polymorphic enzyme glutathione transferase P1-1: kinetic properties and crystallographic characterisation of allelic variants.
Lorien J Parker, Sarah Ciccone, Louis C Italiano, Alessandra Primavera, Aaron J Oakley, Craig J Morton, Nancy C Hancock, Mario Lo Bello, Michael W Parker. J Mol Biol 2008
37
100

Chemistry. Nanomaterials for drug delivery.
Jeffrey A Hubbell, Ashutosh Chilkoti. Science 2012
268
100


Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives.
Gantumur Battogtokh, Yeon Su Choi, Dong Seop Kang, Sang Jun Park, Min Suk Shim, Kang Moo Huh, Yong-Yeon Cho, Joo Young Lee, Hye Suk Lee, Han Chang Kang. Acta Pharm Sin B 2018
100
100

The role of glutathione-S-transferase in anti-cancer drug resistance.
Danyelle M Townsend, Kenneth D Tew. Oncogene 2003
792
100

Targeted combinational therapy inducing mitochondrial dysfunction.
Weon Sup Shin, Soon Ki Park, Peter Verwilst, Seyoung Koo, Joung Hae Lee, Sung-Gil Chi, Jong Seung Kim. Chem Commun (Camb) 2017
12
100



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.